gamma-Amino-beta-hydroxybutyric acid
Clinical data | |
---|---|
Trade names | Gamibetal, others |
Other names | Buxamine; Buxamina; Bussamina; γ-Amino-β-hydroxybutyric acid; GABOB; β-Hydroxy-γ-aminobutyric acid; β-Hydroxy-GABA |
Identifiers | |
| |
JSmol) | |
| |
|
γ-Amino-β-hydroxybutyric acid (GABOB), also known as β-hydroxy-γ-aminobutyric acid (β-hydroxy-GABA), and sold under the brand name Gamibetal among others, is an
Medical uses
GABOB is an anticonvulsant and is used in the treatment of epilepsy.[1][2]
Pharmacology
GABOB is a
Relative to GABA, GABOB has more potent inhibitory effects on the central nervous system, perhaps due to its greater capacity to cross the blood–brain barrier.[5][8] However, GABOB is of relatively low potency as an anticonvulsant when used by itself, and is more useful as an adjuvant treatment used alongside another anticonvulsant.[9][10]
Chemistry
GABOB, or β-hydroxy-GABA, is a close
Society and culture
Generic name
GABOB has been referred to by the
Brand names
GABOB is sold primarily under the brand name Gamibetal.[1] It has also been marketed under a variety of other brand names including Aminoxan, Bogil, Diastal, Gabimex, Gabomade, Gaboril, Gamalate, and Kolpo.[1][12]
References
- ^ ISBN 978-3-88763-075-1.
- ^ ISBN 978-1-4665-7789-3.
- ISBN 978-0-19-514007-1.
- S2CID 71239193.
- ^ PMID 13642322.
- ^ ISBN 978-3-319-46044-4.
- PMID 6267220.
- S2CID 1436623.
- PMID 7466221.
- PMID 9711762.
- PMID 11830761.
- ISBN 978-3-7692-2114-5.